Quick Search


 

Result Summaries: abacavir/lamivudine

ViiV
Study ID
   Phase    Title Summary (Download)
103441 Phase 3 A Randomised, Open-Label Study to Evaluate the Efficacy and Safety of a treatment optimisation with Trizivir during 96 weeks after a first antiretroviral treatment in HIV-1 Infected Subjects (0 citation(s)) Click here to download result summary.
104807 Phase 4 Post-Marketing Clinical Study of EPZICOM Tablet (Lamivudine / Abacavir Sulfate) – Pharmacokinetic Study in HIV-Infected Patients – (0 citation(s)) Click here to download result summary.
107362 phase 4 HIV Model Fixed Dosed Combination Outcomes (1 citation(s)) Click here to download result summary.
111950_4 n\a Fractures over time stratified by HIV infection and Antiretroviral Therapy (ART) exposure (0 citation(s)) Click here to download result summary.
112872_4 n\a HIV treatment and CVD events - Ingenix. Retrospective Database Analysis of Patients with Human Immunodeficiency Virus (HIV) Treatment and Cardiovascular Disease (CVD) Events (0 citation(s)) Click here to download result summary.
112877_6 N/A Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration (5 citation(s)) Click here to download result summary.
112878_6 N/A Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus (0 citation(s)) Click here to download result summary.
112879_1 N/A Incidence of abacavir hypersensitivity reactions in EuroSIDA (1 citation(s)) Click here to download result summary.
112885_4 N/A Antiretroviral Pregnancy Registry (APR)-Risk of birth defects associated with exposure to GSK HIV drugs during pregnancy (1 citation(s)) Click here to download result summary.
112887_4 N/A Studies using DAD - Effects of different interventions to improve ART-associated dyslipidemia (1 citation(s)) Click here to download result summary.
113039_4 N/A Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles? (1 citation(s)) Click here to download result summary.
113156_4 N/A Studies using the VA - Studies done under the Oversight Committee for the Evaluation of the metabolic complications of HAART (2 citation(s)) Click here to download result summary.
113329_4 n\a Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC ) (2 citation(s)) Click here to download result summary.
113734 phase 4 A Prospective, Randomized, Multicenter, Open-Label Study to Compare the Efficacy and Safety of Simplifying from a Regimen of Atazanavir (ATV) + Ritonavir (RTV) + Tenofovir/Emtricitabine to ATV + Abacavir/Lamivudine Without RTV in Virologically Suppressed, HIV-1 Infected, HLA-B*5701 Negative Subjects (4 citation(s)) Click here to download result summary.
116287 N/A An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety of KIVEXA(abacavir/lamivudine) administered in Korean patients according to the prescribing information (0 citation(s)) Click here to download result summary.
ESS30008 phase 3 A Phase III, 48-Week, Open-Label, Randomized, Multicenter Study of the Safety and Efficacy of the Abacavir/Lamivudine Fixed-Dose Combination Tablet Administered QD Versus Abacavir + Lamivudine Administered BID in Combination with a PI or NNRTI in Antiretroviral Experienced Patients. (6 citation(s)) Click here to download result summary.
ESS30009 Phase 3 A phase III, randomized, open-label, multicenter study of the safety and efficacy of efavirenz versus tenofovir when administered in combination with the abacavir/lamivudine fixed-dose combination tablet as a once-daily regimen in antiretroviral-naive HIV-1 infected subjects. (1 citation(s)) Click here to download result summary.